These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8931714)

  • 41. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome.
    Mangold E; Pagenstecher C; Leister M; Mathiak M; Rütten A; Friedl W; Propping P; Ruzicka T; Kruse R
    J Med Genet; 2004 Jul; 41(7):567-72. PubMed ID: 15235030
    [No Abstract]   [Full Text] [Related]  

  • 43. MSH-6: extending the reliability of immunohistochemistry as a screening tool in Muir-Torre syndrome.
    Chhibber V; Dresser K; Mahalingam M
    Mod Pathol; 2008 Feb; 21(2):159-64. PubMed ID: 18065960
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients.
    Harwood CA; Swale VJ; Bataille VA; Quinn AG; Ghali L; Patel SV; Dove-Edwin I; Cerio R; McGregor JM
    J Invest Dermatol; 2001 Feb; 116(2):246-53. PubMed ID: 11180000
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mismatch repair proteins expression and microsatellite instability in skin lesions with sebaceous differentiation: a study in different clinical subgroups with and without extracutaneous cancer.
    Cesinaro AM; Ubiali A; Sighinolfi P; Trentini GP; Gentili F; Facchetti F
    Am J Dermatopathol; 2007 Aug; 29(4):351-8. PubMed ID: 17667167
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The importance of functional testing in the genetic assessment of Muir-Torre syndrome, a clinical subphenotype of HNPCC.
    Ollila S; Fitzpatrick R; Sarantaus L; Kariola R; Ambus I; Velsher L; Hsieh E; Andersen MK; Raevaara TE; Gerdes AM; Mangold E; Peltomäki P; Lynch HT; Nyström M
    Int J Oncol; 2006 Jan; 28(1):149-53. PubMed ID: 16327991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Muir-Torre syndrome].
    Körber J; Djawari D
    Hautarzt; 2001 Dec; 52(12):1107-10. PubMed ID: 11910863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy.
    Baudi F; Fersini G; Lavecchia A; Terracciano R; Leone F; Quaresima B; Faniello MC; De Paola L; Doldo P; Cuda G; Costanzo F; Venuta S
    Cancer Lett; 2005 Jun; 223(2):285-91. PubMed ID: 15896463
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of concurrent germ-line mutations in hMSH2 and/or hMLH1 in Japanese hereditary nonpolyposis colorectal cancer kindreds.
    Nakahara M; Yokozaki H; Yasui W; Dohi K; Tahara E
    Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1057-64. PubMed ID: 9419403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MSH-2 and MLH-1 protein expression in Muir Torre syndrome-related and sporadic sebaceous neoplasms.
    Morales-Burgos A; Sánchez JL; Figueroa LD; De Jesús-Monge WE; Cruz-Correa MR; González-Keelan C; Nazario CM
    P R Health Sci J; 2008 Dec; 27(4):322-7. PubMed ID: 19069357
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
    Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
    Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A case of Muir-Torre syndrome associated with mucinous hepatic cholangiocarcinoma and a novel germline mutation of the MSH2 gene.
    Vernez M; Hutter P; Monnerat C; Halkic N; Gugerli O; Bouzourene H
    Fam Cancer; 2007; 6(1):141-5. PubMed ID: 17051350
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes.
    Thibodeau SN; French AJ; Roche PC; Cunningham JM; Tester DJ; Lindor NM; Moslein G; Baker SM; Liskay RM; Burgart LJ; Honchel R; Halling KC
    Cancer Res; 1996 Nov; 56(21):4836-40. PubMed ID: 8895729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer.
    Wang Q; Lasset C; Desseigne F; Saurin JC; Maugard C; Navarro C; Ruano E; Descos L; Trillet-Lenoir V; Bosset JF; Puisieux A
    Hum Genet; 1999; 105(1-2):79-85. PubMed ID: 10480359
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Colonic cancer in a 34-yr-old woman: should it prompt microsatellite instability studies and mismatch repair gene testing?
    Claro I; Cravo M; Glória L; Gaspar C; Albuquerque C; Lage P; Fidalgo P; Ramalho E; Chaves P; Cardoso P; Nobre Leitão C
    Am J Gastroenterol; 1998 Oct; 93(10):1991-2. PubMed ID: 9772075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of mismatch repair proteins in sebaceous gland tumors.
    Popnikolov NK; Gatalica Z; Colome-Grimmer MI; Sánchez RL
    J Cutan Pathol; 2003 Mar; 30(3):178-84. PubMed ID: 12641777
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Germline mutations of hMLH1 and hMSH2 genes in patients with suspected hereditary nonpolyposis colorectal cancer and sporadic early-onset colorectal cancer.
    Yuan Y; Han HJ; Zheng S; Park JG
    Dis Colon Rectum; 1998 Apr; 41(4):434-40. PubMed ID: 9559627
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Muir-Torre syndrome.
    Bhaijee F; Brown AS
    Arch Pathol Lab Med; 2014 Dec; 138(12):1685-9. PubMed ID: 25427047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic linkage analysis in hereditary non-polyposis colon cancer syndrome.
    Froggatt NJ; Koch J; Davies R; Evans DG; Clamp A; Quarrell OW; Weissenbach J; Hodgson SV; Ponder BA; Barton DE
    J Med Genet; 1995 May; 32(5):352-7. PubMed ID: 7616541
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes.
    Wang Y; Friedl W; Lamberti C; Jungck M; Mathiak M; Pagenstecher C; Propping P; Mangold E
    Int J Cancer; 2003 Feb; 103(5):636-41. PubMed ID: 12494471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.